首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1521392

全球植入式心律管理設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Implantable Cardiac Rhythm Management Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球植入式心律管理設備市場需求預計將從 2023 年的 150.7 億美元增至 2032 年的近 278.5 億美元，2024-2032 年研究期間複合年成長率為 7.06%。

植入式心律管理 (CRM) 裝置包括一系列旨在監測和管理心律不整（例如心律不整和心搏過緩）的醫療設備。這些設備透過手術植入體內，其功能是調節心臟的電活動，確保適當的心率和節律。植入式心律管理設備包括透過提供電脈衝刺激心臟來治療心搏過緩的起搏器，以及監測心律並根據需要提供電擊或起搏以防止心臟驟停的植入式心律轉復除顫器( ICD)。

市場動態

全球人口老化，加上心血管疾病的日益流行，患者數量顯著擴大，需要植入式心律管理設備。這種人口結構的變化凸顯了對能夠有效監測和調節心律的植入式設備的日益成長的需求，從而降低與心律不整相關的死亡率。技術和設備功能的進步正在推動市場擴張。設備小型化、更長的電池壽命、增強的診斷功能以及與遠端監控系統的兼容性等創新提高了設備功效和患者治療效果。這些技術進步提高了設備性能，有助於提高患者的便利性和治療依從性。此外，預防性醫療措施和主動慢性病管理的日益採用正在推動植入式心律管理設備的成長。醫療保健提供者和患者對心律不整的早期診斷和介入的好處的認知不斷提高，推動了植入式 CRM 設備的更高利用率。然而，與設備植入和維護相關的高成本以及植入設備的初始費用阻礙了植入式心律管理設備市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球植入式心律管理設備市場的各個細分市場進行了包容性評估。植入式心律管理設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

植入式心律管理設備市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

心律調節器（傳統心律調節器、無引線心律調節器）
ICD（單腔 ICD、雙腔 ICD）
CRT（CRT-除顫器、CRT-心律調節器）

按最終用途

醫院
專科心臟中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲植入式心律管理設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。植入式心律管理設備市場的主要參與者包括美敦力、雅培、波士頓科學公司、皇家飛利浦公司、佐爾醫療公司、百多力、史賽克、席勒公司、日本光電公司、微創科學公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：植入式心律管理設備公司的競爭格局

植入式心律管理設備市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Medtronic

公司簡介
公司收入
產品
最近的發展

Abbott

公司簡介
公司收入
產品
最近的發展

Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Koninklijke Philips NV

公司簡介
公司收入
產品
最近的發展

Zoll Medical Corporation

公司簡介
公司收入
產品
最近的發展

Biotronik

公司簡介
公司收入
產品
最近的發展

Stryker

公司簡介
公司收入
產品
最近的發展

Schiller AG

公司簡介
公司收入
產品
最近的發展

Nihon Kohden Corporation

公司簡介
公司收入
產品
最近的發展

Microport Scientific Corporation

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115231

The global demand for Implantable Cardiac Rhythm Management Devices Market is presumed to reach the market size of nearly USD 27.85 Billion by 2032 from USD 15.07 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Implantable cardiac rhythm management (CRM) devices encompass a range of medical devices designed to monitor and manage heart rhythm disorders, such as arrhythmias & bradycardia. These devices are surgically implanted within the body and function to regulate the heart's electrical activity, ensuring appropriate heart rate and rhythm. Implantable cardiac rhythm management devices include pacemakers for treating bradycardia by delivering electrical impulses to stimulate the heart and implantable cardioverter-defibrillators (ICDs) that monitor heart rhythms and deliver shocks or pacing as needed to prevent sudden cardiac arrest.

MARKET DYNAMICS

An aging population globally, coupled with the increasing prevalence of cardiovascular diseases, is significantly expanding the patient pool, requiring implantable cardiac rhythm management devices. This demographic shift highlights the growing need for implantable devices that can effectively monitor and regulate heart rhythms, thereby reducing mortality rates associated with cardiac arrhythmias. Advancements in technology and device capabilities are driving market expansion. Innovations such as miniaturization of devices, longer battery life, enhanced diagnostic features, and compatibility with remote monitoring systems improve device efficacy and patient outcomes. These technological advancements enhance device performance and contribute to patient convenience and compliance with therapy. Moreover, the rising adoption of preventive healthcare measures and proactive chronic disease management are fuelling the growth of implantable cardiac rhythm management devices. Rising awareness among healthcare providers & patients about the benefits of early diagnosis and intervention for cardiac rhythm disorders drives higher utilization of implantable CRM devices. However, the high costs associated with device implantation and maintenance and the initial expense of implantable devices, pose hinder the implantable cardiac rhythm management devices market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Implantable Cardiac Rhythm Management Devices. The growth and trends of Implantable Cardiac Rhythm Management Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Implantable Cardiac Rhythm Management Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Pacemaker (Conventional Pacemakers, Leadless Pacemaker)
ICDs (Single Chamber ICDs, Dual Chamber ICDs)
CRT (CRT-Defibrillator, CRT-Pacemaker)

By End-Use

Hospitals
Specialty Cardiac Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Implantable Cardiac Rhythm Management Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Implantable Cardiac Rhythm Management Devices market include Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik, Stryker, Schiller AG, Nihon Kohden Corporation, Microport Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-Use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Historic and Forecast Sales By Regions
5.4. ICDs (Single Chamber ICDs, Dual Chamber ICDs) Historic and Forecast Sales By Regions
5.5. CRT (CRT-Defibrillator, CRT-Pacemaker) Historic and Forecast Sales By Regions

6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY END-USE

6.1. Overview By End-Use
6.2. Historical and Forecast Data Analysis By End-Use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Specialty Cardiac Centers Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES COMPANIES

8.1. Implantable Cardiac Rhythm Management Devices Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Abbott
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boston Scientific Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Koninklijke Philips N.V.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Zoll Medical Corporation
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Biotronik
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Stryker
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Schiller AG
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Nihon Kohden Corporation
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Microport Scientific Corporation
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Market Sales By Geography (USD MN)
ICDs (Single Chamber ICDs, Dual Chamber ICDs) Market Sales By Geography (USD MN)
CRT (CRT-Defibrillator, CRT-Pacemaker) Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Specialty Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Implantable Cardiac Rhythm Management Devices Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Implantable Cardiac Rhythm Management Devices Report
Market Research Process
Market Research Methodology
Global Implantable Cardiac Rhythm Management Devices Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Market Sales By Geography (USD MN)
ICDs (Single Chamber ICDs, Dual Chamber ICDs) Market Sales By Geography (USD MN)
CRT (CRT-Defibrillator, CRT-Pacemaker) Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Specialty Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis